Please Note:
This profile was automatically generated using 15 references found on the Internet. This information has been verified by Thomas Abbott. Learn more...
This profile was automatically generated using 15 references found on the Internet. This information has been verified by Thomas Abbott. Learn more...
View all 15 references Web References
-
1. www.pmrg.org
www.pmrg.org/EventsAwards/TheP - [Cached]Published on: 6/26/2008 Last Visited: 6/26/2008
Thomas A. Abbott IIIPresident
...
Tom Abbott leads i3's newest business unit focused on the application of i3's unique data assets and technology to support pharmaceutical, biotechnology and device manufactures' sales and marketing activities.Tom has over 16 years of experience managing, designing, and conducting market research and health outcomes studies.Tom began his career as a faculty member at the Graduate School of Management, Rutgers University in 1987.In 1995 Tom joined the pharmaceutical industry as a Director, Outcomes Research and Management at Merck & Co.Inc. where he held several other leadership positions.In 2004, Tom assumed a leadership position at Thomson-Medstat and most recently was Vice President Brand Analytics at Wolters-Kluwer.Tom has a PhD in Economics from Harvard (1987), a Post-Doc in Health Services Research from Yale (1993) and an MBA from the Wharton School at the University of Pennsylvania (2003). -
2. 9th Annual Meeting Planning Committee
www.ispor.org/meetings/va0504/ - [Cached]Published on: 11/22/2001 Last Visited: 12/11/2005
Thomas Abbott PhD, MBA, Senior Director, Pharmaceutical Economics Merck & Co.Inc., US -
3. DEVELOPING STANDARDS FOR DRUG COSTS IN PHARMACOECONOMIC STUDIES
www.ispor.org/councils/issues. - [Cached]Published on: 8/18/2006 Last Visited: 7/14/2008
Lou Garrison, PhD,1 Ed Mansley, PhD,2 Thomas A. Abbott III, PhD, MBA,3 Brian Bresnahan, PhD,4 Leslie Wilson, PhD,5 Joel W. Hay, PhD,6 Jim Smeeding RPh, MBA,7
